BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ABBV-319 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ABBV-319\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05512390-5628@assetmemo.bio
DTSTAMP:20261121T004045Z
DTSTART;VALUE=DATE:20270228
DTEND;VALUE=DATE:20270301
SUMMARY:ABBV-319: Phase 1 readout est. (NCT05512390)
DESCRIPTION:ABBV-319\, phase 1.\nStudy: A Study to Assess the Adverse Event
 s\, Change in Disease Activity\, and How Intravenously Infused ABBV-319 Mo
 ves Through the Bodies of Adult Participants With Relapsed or Refractory (
 R/R) Diffuse Large B-cell Lymphoma (DLBCL)\, Follicular Lymphoma (FL)\, or
  Chronic Lymphocytic Leukemia (CLL)\nEstimated primary completion: Februar
 y 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout da
 te\, and it can move.\nDrug page: https://assetmemo.bio/drug/abbv-319#upco
 ming-events\nRegistry record: https://clinicaltrials.gov/study/NCT05512390
URL:https://assetmemo.bio/drug/abbv-319#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06977724-5628@assetmemo.bio
DTSTAMP:20261121T004045Z
DTSTART;VALUE=DATE:20290331
DTEND;VALUE=DATE:20290401
SUMMARY:ABBV-319: Phase 1 readout est. (NCT06977724)
DESCRIPTION:ABBV-319\, phase 1\, Systemic Lupus Erythematosus.\nStudy: A St
 udy to Assess Adverse Events\, How the Drug Moves Through the Body and Eff
 ectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With
  Systemic Lupus Erythematosus (SLE)\, Sjogren's Disease (SjD) and Rheumato
 id Arthritis (RA)\nEstimated primary completion: March 2029. This is a Cli
 nicalTrials.gov estimate\, not a confirmed readout date\, and it can move.
 \nDrug page: https://assetmemo.bio/drug/abbv-319#upcoming-events\nRegistry
  record: https://clinicaltrials.gov/study/NCT06977724
URL:https://assetmemo.bio/drug/abbv-319#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
